Home/Filings/4/0001209191-15-048133
4//SEC Filing

OXIGENE INC 4

Accession 0001209191-15-048133

$OTLCCIK 0000908259operating

Filed

May 28, 8:00 PM ET

Accepted

May 29, 9:18 PM ET

Size

8.3 KB

Accession

0001209191-15-048133

Insider Transaction Report

Form 4
Period: 2015-05-28
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-05-28+75,00075,000 total
    Exercise: $1.43Exp: 2025-05-28Common Stock (75,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2015-05-28+300,000300,000 total
    Exercise: $1.43Exp: 2025-05-28Common Stock (300,000 underlying)
Footnotes (3)
  • [F1]Dr. Schwieterman was awarded options to purchase OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options") pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan in connection with his service as President and Chief Executive Officer.
  • [F2]The Stock Options will vest upon the occurrence of a change of control (as such term is defined in Dr. Schwieterman's Employment Agreement with OXiGENE, Inc., dated May 12, 2015) and the value of OXiGENE, Inc.'s common stock in connection with such change of control is at least $15.00 per share, as adjusted for stock splits, if any.
  • [F3]25% of the Stock Options will vest on the first anniversary of the date of grant and the remainder will vest in 36 substantially equal monthly installments beginning one year and one month after the grant date.

Issuer

OXIGENE INC

CIK 0000908259

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000908259

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 9:18 PM ET
Size
8.3 KB